Skip to main content
. Author manuscript; available in PMC: 2009 Aug 7.
Published in final edited form as: Paediatr Perinat Epidemiol. 2009 Mar;23(2):171–184. doi: 10.1111/j.1365-3016.2008.00985.x

Table 5.

Cycle visit blood and urine specimen collection

Collection tube
(anticoagulant) (no.
tubes × volume)
Specimen type No. of
aliquots × volumea
Test to be performedb Methodb Testlabc
Lavendar top
  (EDTA)
  (2 × 10 mL)
Whole blood 1 × 0.15 Total haemoglobin (Hgb) Cyan met haemoglobin
  method
UB
Whole blood 0.15 mL stabilised into
  1.35 mL PCA
Thiols (e.g. glutathione,
  glutathione disulphide)
Stored future use UB
EDTA plasma 1 × 1.25 mL F2-8-isoprostanes GC-MS U Minn
EDTA plasma 1 × 1.1 mL Lipid peroxidation profile HPLC UB
EDTA plasma 1 × 0.75 mL TBARS Spectrofluorometry UB
EDTA plasma 1 × 0.75 mL NMR lipoproteins
  (1 per cycle)
NMR Liposcience
EDTA plasma 1 × 1.1 mL Homocysteine
  (3 per cycle)
CL-EIA Kalieda
EDTA plasma 1 × 1.25 mL Extra stored
EDTA plasma 8 × 0.6 mL Extra stored
Buffy coat Stored buffy coat Future DNA extraction
Green top
  (sodium
  heparin)
  (1×5 mL)
Heparin plasma 0.5 stabilised into
  2.0 mL MPA
Vitamin C DNPH Colorimetric assay UB
Heparin plasma 1 × 0.3 mL Plasma glutathione
  peroxidase
Kinetic enzyme assay UB
Heparin plasma 3 × 0.6 mL Extra stored
Buffy coat 1 × 0.5 mL Stored for DNA extraction
Washed
  erythrocytes
1 × 0.5 mL Antioxidant enzymes
  (SOD, GPx, GSHR)
Kinetic enzyme assay UB
Red top (no
  anticoagulant)
  (1 × 10 mL;
  1 × 15 mL)
Serum 1 × 0.3 mL PON Kinetic enzyme assay UB
Serum 1 × 1.1 mL Fat soluable vitamins HPLC UB
Serum 1 × 1.25 mL CMP Auto chemistry analyser Kalieda
Lipid profile Auto chemistry analyser Kalieda
Uric acid Colorimetry Kalieda
Bilirubin Colorimetry Kalieda
hsCRP CL-EIA Kalieda
Serum 1 × 0.6 mL Oestradiol Radio immunoassay Kalieda
Serum 1 × 2.0 mL Insulin, progesterone,
  LH, FSH, SHBG
CL-EIA Kalieda
Serum 8 × 0.6 mL Extra stored
Urine Spot urine 7 × 4.0 mL Extra stored
Cytokines Luminex flow cytometry Gainesville
a

PCA, perchloric acid stabilising solution; MPA, meta-phosphoric acid stabilising solution.

b

CL-EIA, DPC Inc., Immunlite 2000 Solid phase competitive Chemiluminescent Enzymatic Immunoassay; DNPH, dinitrophenyl hydrazine; EDTA, ethylenediamine tetraacetic acid; FSH, follicle-stimulating hormone; GC-MS, gas chromatograph-mass spectrometry; GPx, glutathione peroxidase; GSHR, glutathione reductase; hsCRP, high sensitivity C-reactive protein; LH, lutinising hormone; NMR, nuclear magnetic resonance spectroscopy; PON, paraoxinase; SHBG, sex hormone binding globulin; SOD, superoxide dismutase; TBARS, thiobarbituric acid reactive substances.

c

UB, Dr Richard Browne, University at Buffalo, Buffalo NY; Kaleida Health Laboratories, Buffalo NY; U Minn, Dr Myron Gross, University of Minnesota, Minneapolis, MN; Liposicence, Raleigh, NC; Gainesville, Dr Chegini, U Florida, Gainesville, FL. Note blood draw order was: 15 mL red, 10 mL lavender, 4 mL green, 10 mL lavender, 10 mL red.